Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease

Sherif M Badawy; Alexis A Thompson; Jin-Shei Lai; Frank J Penedo; Karen Rychlik; Robert I Liem

doi:10.1002/pbc.26369

Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease

Sherif M Badawy^*, Alexis A Thompson, Jin-Shei Lai, Frank J Penedo, Karen Rychlik, Robert I Liem

^*Corresponding author for this work

Research output: Contribution to journal › Article

29 Scopus citations

Abstract

Background: Complications related to sickle cell disease (SCD) result in significant declines in health-related quality of life (HRQOL). While hydroxyurea reduces SCD complications, adherence remains suboptimal. The study's objectives were to assess the feasibility of Internet-based electronic assessment of HRQOL in SCD clinic and to examine the relationship between HRQOL and hydroxyurea adherence in adolescents and young adults (AYAs) with SCD. Procedure: A cross-sectional survey was administered on tablets to 34 AYAs (12–22 years old) in a SCD clinic from January through December 2015. Study measures included Patient Reported Outcomes Measurement Information System (PROMIS^®) computerized adaptive testing and

Original language	English (US)
Article number	e26369
Journal	Pediatric Blood and Cancer
Volume	64
Issue number	6
DOIs	https://doi.org/10.1002/pbc.26369
State	Published - Jun 1 2017

Keywords

PROMIS
adherence
adolescents
compliance
health-related quality of life
hydroxyurea
patient-reported outcomes
patient-reported outcomes measurement information system
sickle cell anemia
sickle cell disease
young adults

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Hematology
Oncology

Access to Document

10.1002/pbc.26369

Fingerprint Dive into the research topics of 'Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease'. Together they form a unique fingerprint.

Cite this

Badawy, S. M., Thompson, A. A., Lai, J-S., Penedo, F. J., Rychlik, K., & Liem, R. I. (2017). Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease. Pediatric Blood and Cancer, 64(6), [e26369]. https://doi.org/10.1002/pbc.26369

@article{12a17772059245388787650108578e84,

title = "Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease",

abstract = "Background: Complications related to sickle cell disease (SCD) result in significant declines in health-related quality of life (HRQOL). While hydroxyurea reduces SCD complications, adherence remains suboptimal. The study's objectives were to assess the feasibility of Internet-based electronic assessment of HRQOL in SCD clinic and to examine the relationship between HRQOL and hydroxyurea adherence in adolescents and young adults (AYAs) with SCD. Procedure: A cross-sectional survey was administered on tablets to 34 AYAs (12–22 years old) in a SCD clinic from January through December 2015. Study measures included Patient Reported Outcomes Measurement Information System (PROMIS{\textregistered}) computerized adaptive testing and",

keywords = "PROMIS, adherence, adolescents, compliance, health-related quality of life, hydroxyurea, patient-reported outcomes, patient-reported outcomes measurement information system, sickle cell anemia, sickle cell disease, young adults",

author = "Badawy, {Sherif M} and Thompson, {Alexis A} and Jin-Shei Lai and Penedo, {Frank J} and Karen Rychlik and Liem, {Robert I}",

year = "2017",

month = jun,

day = "1",

doi = "10.1002/pbc.26369",

language = "English (US)",

volume = "64",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "6",

}

TY - JOUR

T1 - Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease

AU - Badawy, Sherif M

AU - Thompson, Alexis A

AU - Lai, Jin-Shei

AU - Penedo, Frank J

AU - Rychlik, Karen

AU - Liem, Robert I

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Background: Complications related to sickle cell disease (SCD) result in significant declines in health-related quality of life (HRQOL). While hydroxyurea reduces SCD complications, adherence remains suboptimal. The study's objectives were to assess the feasibility of Internet-based electronic assessment of HRQOL in SCD clinic and to examine the relationship between HRQOL and hydroxyurea adherence in adolescents and young adults (AYAs) with SCD. Procedure: A cross-sectional survey was administered on tablets to 34 AYAs (12–22 years old) in a SCD clinic from January through December 2015. Study measures included Patient Reported Outcomes Measurement Information System (PROMIS®) computerized adaptive testing and

AB - Background: Complications related to sickle cell disease (SCD) result in significant declines in health-related quality of life (HRQOL). While hydroxyurea reduces SCD complications, adherence remains suboptimal. The study's objectives were to assess the feasibility of Internet-based electronic assessment of HRQOL in SCD clinic and to examine the relationship between HRQOL and hydroxyurea adherence in adolescents and young adults (AYAs) with SCD. Procedure: A cross-sectional survey was administered on tablets to 34 AYAs (12–22 years old) in a SCD clinic from January through December 2015. Study measures included Patient Reported Outcomes Measurement Information System (PROMIS®) computerized adaptive testing and

KW - PROMIS

KW - adherence

KW - adolescents

KW - compliance

KW - health-related quality of life

KW - hydroxyurea

KW - patient-reported outcomes

KW - patient-reported outcomes measurement information system

KW - sickle cell anemia

KW - sickle cell disease

KW - young adults

UR - http://www.scopus.com/inward/record.url?scp=85006237829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006237829&partnerID=8YFLogxK

U2 - 10.1002/pbc.26369

DO - 10.1002/pbc.26369

M3 - Article

C2 - 27896936

AN - SCOPUS:85006237829

VL - 64

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 6

M1 - e26369

ER -